Abstract
T lymphocytes generally fail to recognize human colon carcinomas, suggesting that the tumour is beyond reach of immunotherapy. Bacterial superantigens are the most potent known activators of human T lymphocytes and induce T cell cytotoxicity and cytokine production. In order to develop a T-cell-based therapy for colon cancer, the superantigen staphylococcal enterotoxin A (SEA) was given tumour reactivity by genetic fusion with a Fab fragment of the monoclonal antibody C242 reacting with human colon carcinomas. The C242Fab-SEA fusion protein targeted SEA-reactive T cells against MHC-class-II-negative human colon carcinoma cells in vitro at nanomolar concentrations. Treatment of disseminated human colon carcinomas growing in humanized SCID mice resulted in marked inhibition of tumour growth and the apparent cure of the animals. Therapeutic efficiency was dependent on the tumour specificity of the fusion protein and human T cells. Immunohistochemistry demonstrated massive infiltration of human T cells in C242Fab-SEA-treated tumours. The results merit further evaluation of C242Fab-SEA fusion proteins as immunotherapy in patients suffering from colon carcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Björk P, Jönsson U, Svedberg H, Larsson K, Lind P, Dillner J, Hedlund G, Dohlsten M, Kalland T (1993) Isolation, partial characterization and molecular cloning of a human colon adenom carcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody. J Biol Chem 268: 2432
Chen L, Ashe S, Brady WA, Hellstrom I, Hellström KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte moleuces CD28 and CTLA-4. Cell 71: 1093
Dohlsten M, Hedlund G, Lando PA, Trowsdale J, Altmann D, Patarroyo M, Fischer H, Kalland T (1991) Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin mediated cytotoxicity. Eur J Immunol 21: 131
Dohlsten M, Hedlund G, Åkerblom E, Lando PA, Kalland T (1991) Monoclonal antibody-targeted superantigens: a different class of anti-tumour agents. Proc Natl Acad Sci USA 88: 9287
Dohlsten M, Sundstedt A, Björklund M, Hedlung G, Kalland T (1993) Superantigen-induced cytokines suppress growth of human colon-carcinoma cells. Int J Cancer 54: 482
dohlsten M, Abrahmsén L, Björk P, Lando PA, Hedlund G, Forsberg G, Brodin T, Gascoigne NR, Förberg C, Lind P, Kalland T (1994) Monoclonal antibody-superantigen fusion proteins: Tumour-specific agents for T-cell-based tumor therapy. Proc Natl Acad Sci USA 91: 8945
Fischer H, Dohlsten M, Andersson U, Hedlund G, Ericsson P-O, Hansson J, Sjögren H-O (1990) Production of TNFα and TNFβ by staphylococcal enterotoxin A activated human T cells. J Immunol 144: 4663
Lando P, Dohlsten M, Hedlund G, Åkerblom E, Kalland T (1993) T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens. Cancer Immunol Immunother 36: 223
Larson LN, Johansson C, Lindholm L, Holmgren H (1988) Mouse monoclonal antibodies for experimental immunotherapy promotes killing of tumour cells. Int J Cancer 42: 877
Momburg F, Ziegler A, Harpprecht J, Möller P, Moldenhauer G, Hammerling GJ (1989) Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J Immunol 142: 352
Ochi A, Migita K, Xu J, Siminovitch K (1993) In vivo tumor immunotherapy by a bacterial superantigen. J Immunol 151: 3180
Renner C, Jung W, Sahin U, Denfeld R, Pohl C, Trumper L, Hartmann F, Diehl V, Lier R van, Pfreundschuh M (1994) Cure of xenografted human tumours by bispecific monoclonal antibodies and human T cells. Science 264: 833
Riethmüller G, Johnson JP (1992) Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr Opin Immunol 4: 647
Scherer MT, Ignatowicz L, Winslow G, Kappler J, Marrack P (1993) Superantigens: bacterial and viral proteins that manipulate the immune system. Annu Rev Cell Biol 9: 101
Torbett BE, Picchio G, Mosier DE (1991) hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunol Rev 124: 139
Yoo Y-K, Heo DS, Van Thiel DH, Whiteside TL (1990) Tumorinfiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2. Gastroenterology 98: 259
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dohlsten, M., Lando, P.A., Björk, P. et al. Immunotherapy of human colon cancer by antibody-targeted superantigens. Cancer Immunol Immunother 41, 162–168 (1995). https://doi.org/10.1007/BF01521342
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01521342